Literature DB >> 32761135

Retinal Vasculitis After Administration of Brolucizumab Resulting in Severe Loss of Visual Acuity.

Srinivas Sai A Kondapalli1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32761135     DOI: 10.1001/jamaophthalmol.2020.2810

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  7 in total

1.  Angiographic findings before and after the onset of brolucizumab-associated retinal vascular occlusion and intraocular inflammation.

Authors:  Sentaro Kusuhara; Kyung Woo Kim; Akiko Miki; Makoto Nakamura
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-14

2.  Swept-source optical coherence tomography angiography of retinal occlusive vasculitis following brolucizumab administration: a case report.

Authors:  Eun Kyoung Lee; Baek-Lok Oh; Chang Ki Yoon; Un Chul Park
Journal:  BMC Ophthalmol       Date:  2022-06-03       Impact factor: 2.086

3.  Idiopathic retinal arterial occlusive vasculitis in the setting of multiple arterial occlusions.

Authors:  Patrick Wang; Eric K Chin; David Rp Almeida
Journal:  Am J Ophthalmol Case Rep       Date:  2021-04-08

Review 4.  Side Effects of Brolucizumab.

Authors:  Tahmineh Motevasseli; Saeed Mohammadi; Fatemeh Abdi; William R Freeman
Journal:  J Ophthalmic Vis Res       Date:  2021-10-25

5.  Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD.

Authors:  Ramin Khoramnia; Marta S Figueroa; Lars-Olof Hattenbach; Carlos E Pavesio; Majid Anderesi; Robert Schmouder; Yu Chen; Marc D de Smet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-12-21       Impact factor: 3.535

Review 6.  A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Patient Selection, Evaluation, and Treatment.

Authors:  Frank G Holz; Tomohiro Iida; Ichiro Maruko; SriniVas R Sadda
Journal:  Retina       Date:  2022-06-13       Impact factor: 3.975

Review 7.  Update on Retinal Drug Toxicities.

Authors:  S Tammy Hsu; Arathi Ponugoti; Jordan D Deaner; Lejla Vajzovic
Journal:  Curr Ophthalmol Rep       Date:  2021-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.